Press release
Anti-Inflammatory Drugs Market Outlook by Examining the Results of Different Competitors Through 2031 - Amgen Inc, AstraZeneca, Merck & Co.
Anti-Inflammatory Drugs Market
Will the Anti-Inflammatory Drugs Market become the sector's next big opportunity? To find out, delve into the analysis and projections for Anti-Inflammatory Drugs Market. This market research study offers in-depth insights into the opportunities, challenges, and trends currently shaping the machinery landscape, enabling industry participants to make informed decisions in a dynamic environment. Take advantage of the opportunity in the Anti-Inflammatory Drugs Market! (2031)
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/anti-inflammatory-drugs-market
The Global Anti-Inflammatory Drugs Market reached USD 87.7 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 170.1 billion by 2031. The Global Anti-Inflammatory Drugs Market is expected to exhibit a CAGR of 8.8% during the forecast period 2024-2031.
Key Growth Drivers in Anti-Inflammatory Drugs Market:
Anti-inflammatory drugs are medications that reduce inflammation and relieve pain associated with various conditions. They can be classified into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and aspirin, and corticosteroids, which are used for more severe inflammatory responses. These drugs work by inhibiting specific enzymes or pathways involved in the inflammatory process, providing relief for conditions like arthritis, muscle pain, and inflammatory bowel disease. Ongoing research aims to develop more targeted anti-inflammatory therapies with fewer side effects, enhancing patient outcomes and quality of life.
DataM Intelligence profiles some of the most reputed organizations present in the Anti-Inflammatory Drugs market. They are as follows:
Amgen Inc, AstraZeneca, Merck & Co., GlaxoSmithKline, Bristol-Myers Squibb, F-Hoffmann-La-Roche, Eli Lilly, Sanofi, Abbot Laboratories, and Boehringer Ingelheim GmbH.
Segment Covered in the Anti-Inflammatory Drugs Market:
By Treatment: Arthritis, Chronic obstructive pulmonary disease (COPD), Multiple Sclerosis, Inflammatory bowel disease (IBD), Asthma, Tendonitis, Other.
By Drug Class: Anti-Inflammatory Biologics, Nonsteroidal anti-inflammatory drugs (NSAIDS), Corticosteroids, Immune-selective anti-inflammatory derivative (IMSAID), Indigestion, Additional Supplements, Other.
By Distribution Channel: Hospital Pharmaceutical shop, Retail Pharmaceutical Stores, Clinics, Others.
Regional Analysis:
The global Anti-Inflammatory Drugs Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
Key Developments
AMJEVITA (adalimumab-atto) is a biosimilar medication introduced by Amgen in January 2023, specifically designed to be a cost-effective alternative to Humira (adalimumab). Approved by the US Food and Drug Administration (FDA) in 2016, AMJEVITA became the first biosimilar of Humira, which has been widely used to treat a variety of severe inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, and Crohn's disease.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=anti-inflammatory-drugs-market
Regional Analysis:
The global Anti-Inflammatory Drugs Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Anti-Inflammatory Drugs Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Points Covered:
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Anti-Inflammatory Drugs market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Anti-Inflammatory Drugs Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The global Anti-Inflammatory Drugs market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Anti-Inflammatory Drugs Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/anti-inflammatory-drugs-market
FAQ's
Q.1. What are the primary drivers of the Anti-Inflammatory Drugs Industry?
Q.2. What are the main factors propelling and impeding the growth of the Anti-Inflammatory Drugs market?
Q.3. What are the general structure, risks, and opportunities of the market?
Q.4. How do the prices, revenue, and sales of the leading Anti-Inflammatory Drugs market firms compare?
Q.5. What are the main segments of the market and how is it divided up?
Q.6. Which companies dominate the market, and what percentage of the market do they control?
Q.7. What trends are influencing the Anti-Inflammatory Drugs market now and in the future?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Inflammatory Drugs Market Outlook by Examining the Results of Different Competitors Through 2031 - Amgen Inc, AstraZeneca, Merck & Co. here
News-ID: 3699536 • Views: …
More Releases from DataM Intelligence 4market Research LLP
United States Natural Astaxanthin Market to Reach USD 1.5 Billion by 2031, Growi …
Global Natural Astaxanthin Market reached US$ 0.84 billion in 2023 and is expected to reach US$ 1.5 billion by 2031, growing with a CAGR of 7.7% during the forecast period 2024-2031.
The Natural Astaxanthin Market focuses on the use of astaxanthin, a powerful antioxidant derived from microalgae, in industries like food and beverages, pharmaceuticals, cosmetics, and nutraceuticals. Known for its health benefits, such as reducing inflammation and supporting skin health, the…
Remote Browser Isolation Market reached US$ 0.59 billion in 2024 and is expected …
Remote Browser Isolation Market reached US$ 0.59 billion in 2024 and is expected to reach US$ 5.35 billion by 2032, growing with a CAGR of 31.75% during the forecast period 2025-2032.
Remote Browser Isolation (RBI) is a cybersecurity technology that separates a user's web browsing activity from their local network and endpoints by running the browser sessions on remote servers. This approach prevents malware, ransomware, and phishing attacks from reaching the…
United States Liquid Chromatography Mass Spectrometry Market to Reach USD 19.10 …
The Liquid Chromatography Mass Spectrometry Market size reached US$ 6.78 billion in 2024 and is expected to reach US$ 19.10 billion by 2032, growing with a CAGR of 13.82% during the forecast period 2025-2032.
LC-MS combines liquid chromatography and mass spectrometry for highly sensitive chemical, proteomic, and pharmaceutical analysis. Growth is driven by drug discovery, clinical diagnostics, and environmental testing. Applications include metabolomics, food safety, and biomarker identification. Research labs, pharmaceutical…
United States Algae-Based Food Products Market Outlook 2024-2031: Rising Demand …
Global Algae-Based Food Products Market reached US$ 2.1 billion in 2023 and is expected to reach US$ 3.8 billion by 2031, growing with a CAGR of 7.69 % during the forecast period 2024-2031.
The Algae-Based Food Products Market includes functional foods, beverages, and supplements made from spirulina, chlorella, and other algae. Growth is driven by health trends, vegan diets, and sustainability awareness. Products provide protein, omega-3s, antioxidants, and vitamins. Food manufacturers,…
More Releases for Inflammatory
Inflammatory Myositis Market Massive Growth opportunity Ahead
Introduction
Inflammatory myositis is a group of rare autoimmune disorders characterized by chronic inflammation of skeletal muscles, leading to progressive muscle weakness, fatigue, and functional disability. The spectrum includes polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM), immune-mediated necrotizing myopathy (IMNM), and overlap syndromes. These disorders can also involve other organs, most notably the lungs (interstitial lung disease), skin, heart, and joints, complicating disease management.
Historically, corticosteroids and conventional immunosuppressants have formed…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
The Anti-Inflammatory Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Anti-Inflammatory Therapeutics Market Size and Projected Growth Rate?
The market size of anti-inflammatory therapeutics has shown a consistent growth in the past few years. The market is projected to expand from $114.71…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
What market dynamics are playing a key role in accelerating the growth of the anti-inflammatory therapeutics market?
As inflammatory bowel disease becomes more commonplace, it is predicted to encourage progress in the anti-inflammatory therapeutics market. Characterized as a long-term condition causing inflammation of the digestive tract, inflammatory bowel disease (IBD) is effectively managed with the usage of anti-inflammatory therapeutics. These treatments are central in the control of Crohn's disease via decreasing…
Anti-Inflammatory Activity Enzyme Manufacturer | Pearlzyme Inc
Pearlzyme Inc. is a South Korean company that manufactures anti inflammatory activity enzymes. This anti-inflammatory activity enzyme boosts the animal's immune system against infection and increases milk lactation.
Pearlzyme Inc. is committed to providing high-quality products and services to its customers. The company has a team of experienced scientists and engineers who are constantly working to develop new and innovative products. Pearlzyme Inc. is also committed to sustainable development and is…
Inflammatory Bowel Disease Market: The Present and Future of Inflammatory Bowel …
Stratagem Market Insights have included the latest addition of a global market research report titled Inflammatory Bowel Disease Market tits expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant…
Rising incidences of chronic inflammatory and autoimmune diseases has increased …
According to a new report published by apacmarket.com, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period.
Get the sample…
